Regonix

Regorafenib  is an oral multi-kinase inhibitor  involved in normal cellular functioning and in pathological processes such as oncogenesis, tumor angiogenesis, metastasis, and tumor immunity. It is used in the therapy of metastatic colorectal cancer, gastrointestinal stromal tumor and  hepatocellular carcinoma (HCC) who have been previously treated with Sorafenib.

Features